Freedom of information responses show a growing number of English NHS trusts either rejecting Palantir’s data platform or reverting to older systems.
English NHS trusts are quietly debating Palantir’s patient data platform. Freedom of information responses show many trusts either never adopted the FDP or tried it and moved back to older systems. The central question is whether the FDP really delivers beyond existing tools, and what happens if ministers exercise a break clause in the seven-year deal.
What it means for you is simple: it could affect how quickly your hospital can access, share and use your data to schedule care and reduce delays. The government’s decision could push the NHS toward continued use, a switch to other tools, or more local control of data projects.
Next steps aren’t set. A break clause decision could come, or the FDP could remain in some trusts while others pursue alternatives.
The NHS in England is facing mounting questions about Palantir’s patient data platform. Freedom of information responses from more than two dozen NHS bodies show a mix of outcomes: several trusts have not adopted the FDP, while others tested it and then moved back to their prior systems. It highlights how big tech data projects in health care don’t always land as hoped, even when officials point to possible gains.
At stake isn’t just a single software tool. The seven-year contract with Palantir is meant to help bring health data together to improve things like waiting lists and scheduling surgeries. Yet the responses show a range of experiences: some trusts feel the FDP adds little beyond what they already have, while others acknowledge some benefits but don’t see it as essential. For example, one Suffolk trust said other solutions outpace the FDP, and Greater Manchester’s care board described it as duplicative and retrograde.
The wider conversation isn’t only about technology. It feeds into debates over data governance in the NHS, who steers data policy, and whether centralized tools from private firms are the right route. Campaign groups have sharpened their criticisms, arguing the NHS should back homegrown innovation and clinicians who work with data daily rather than rely on a private contractor connected to other government contracts.
Palantir counters that the FDP gives trusts choices tailored to their needs and that it has delivered tangible results where used. A spokesperson noted NHS data showing more operations performed and a drop in discharge delays among FDP users, while stressing that figures can’t prove cause and effect because other factors aren’t controlled for.
The national data guardian, Dr Nicola Byrne, urged ministers to weigh the local experience when deciding the contract. More than 44,000 people have opposed sharing health data with the FDP. In short, concerns about interoperability, value, and trust are shaping opinions across the country.
Where this goes next isn’t set in stone. Ministers could choose to exercise a break clause in the contract, potentially steering the NHS toward alternative interoperability paths or homegrown options. For patients and staff, that could mean changes in how data moves between parts of the system and how quickly care is scheduled.
Bottom line: this is a mosaic of views across England, not a single verdict on Palantir. The coming months will reveal whether the FDP stays in place in some trusts, is scaled back, or is replaced by other solutions.
The FOI responses show a mix: 16 trusts and health boards say they do not use the FDP, and some that have used it report no clear improvements. Trusts publicly praising the FDP include a number of major institutions, while others have said they will not adopt or go live with the platform. The picture varies by region and reflects differing local needs and existing systems.
The platform aims to federate patient data across trusts to give clinicians and managers better visibility into waiting lists and bottlenecks, with the hope of improving accuracy and efficiency. Palantir argues the FDP has helped with scheduling and reducing delays at sites that use it, but NHS leaders emphasize the need for consistent, real-world benefits across many sites.
For patients, the impact isn’t a single feature. It’s about who controls your data and whether a centralized tool can speed up care and reduce delays. If trusts pull back or switch tools, that could affect how quickly hospitals access and share information about your care.
The government must decide whether to exercise a break clause in the contract. If it does, the NHS could pivot to other interoperability approaches or more locally developed options. If not, the FDP may continue in some trusts while others pursue alternatives. Either way, clinicians, patients, and policymakers will be watching how data governance evolves.
There is political and contractual pressure to decide soon, but no final outcome has been announced yet.
Some trusts report improvements, while others say the FDP doesn’t offer more than their current systems. The national question is how widely those gains transfer across the system.
You're reading the quick version.
Read next
Amazon ramps to 27 satellites a week as Leo nears launch
Amazon says its Leo constellation is weeks from offering commercial broadband after building its 1,000th satellite and accelerating production.
Australia plans to require big tech to let users switch off recommended content, part of a wider online safety bill.
Brad Smith says new green-card limits could push skilled workers to other countries, harming the US tech sector.
New talks about a settlement over iPhone competition could tighten interoperability, but developers worry the deal won’t curb Apple’s habits.
The Daily Brief
Every morning, the news that matters from AI, phones, apps and the people shaping tech. Explained in plain English. Free.
One email a day. No spam, unsubscribe anytime. Privacy policy
